Benzinga | Mar 4, 2021 04:26PM EST

NGM Biopharmaceuticals Q4 EPS $(0.40) Down From $(0.24) YoY, Sales $19.77M Down From $31.08M YoY

NGM Biopharmaceuticals (NASDAQ:NGM) reported quarterly losses of $(0.40) per share. This is a 66.67 percent decrease over losses of $(0.24) per share from the same period last year. The company reported $19.77 million in sales this quarter. This is a 36.41 percent decrease over sales of $31.08 million the same period last year.